CARLSBAD, California – October 15, 2024 – Centricity Vision Inc., a global, commercial-stage ophthalmic technology company, today announced new platform enhancements for the ZEPTOLink IOL Positioning System™ which now enables surgeons the ability to control and reduce treatment time by as much as 60%. These platform enhancements will be showcased at the American Academy of…

In this Healio Video Perspective from the ASCRS meeting, Vance Thompson, MD, discusses his experience using Zepto technology for automated capsulotomy. Thompson explained how centering the Zepto (Centricity Vision) over the aligned Purkinje 1 and Purkinje 4 image helps create an image-guided capsulotomy with “a high consistency of 360° of overlap for long-term implant centration and proper tilt.” “It makes my…

Centricity Vision Inc., a global, commercial-stage ophthalmic technology company, today announced that it will present on its recently launched ZEPTOLink IOL Positioning System™ during the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held April 5-8, 2024 in Boston.

Centricity Vision Announces CEO Transition: Leonard Borrmann to Succeed Rob Thornhill as Chief Executive Officer.

Centricity Vision Announces Commercial Launch of ZEPTOLink at AAO Conference in San Francisco.

White cataracts can make the creation of a capsulotomy more challenging.’Review of Ophthalmology’ spoke with Richard Davidson, MD, professor of ophthalmology at the University of Colorado Sue Anschuetz-Rodgers Eye Center how ZEPTO can be a helpful tool in white cataracts.

Centricity Vision is excited to share a new study that demonstrated ZEPTO Precision Pulse Capsulotomy safeguards endothelial cells as effectively as manual capsulorhexis. Learn more in this press release.

In this Healio Video Perspective from Eyecelerator@ASCRS, Rob Thornhill discusses the FDA 510(k) clearance of the ZEPTOLink IOL Positioning System and the benefits the system may provide cataract surgeons.

Centricity Vision Inc., a global ophthalmic technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new ZEPTOLink™ IOL Positioning System. The new platform seamlessly integrates the clinically proven ZEPTO precision pulse capsulotomy technology with any phacoemulsification (phaco) system to streamline cataract surgery.

A recent study found Zepto precision pulse capsulotomy offers significant advantages over manual capsulorhexis in treating white cataracts!  

It’s an honor to be recognized for our ZEPTO IOL Positioning System’s ability to provide greater precision, efficiency, and affordability to practices everywhere! Learn more about Dr. Shalesh Kaushal who recently adopted ZEPTO for his in-office surgical suite.